Company intelligence / Profile preview

New England Compounding Center

Framingham, Massachusetts, United States
Ownership
Private
Development stage
Other
01

Overview

New England Compounding Center (NECC) was a large-scale compounding pharmacy based in Framingham, Massachusetts, that specialized in providing customized medications to healthcare facilities. The company gained international notoriety in 2012 when its contaminated preservative-free methylprednisolone acetate injections caused a massive nationwide fungal meningitis outbreak. This public health crisis resulted in 64 deaths and nearly 800 infections across 20 states, leading to the company's immediate closure and subsequent bankruptcy. The tragedy served as a primary catalyst for the passage of the Drug Quality and Security Act of 2013, which significantly increased federal oversight of compounding pharmacies. Following the outbreak, several company executives faced criminal charges, including co-founder Barry Cadden, who was sentenced to prison.

Therapeutic areas
RheumatologyImmunologyNeurology
Modalities
Small molecule
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on New England Compounding Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on New England Compounding Center.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call